Position in ZYME
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,153,834
New position
Shares Held
565,249
first reported quarter
Ownership
0.774%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026MPM BIOIMPACT LLC holds $1,223,258,298 across 39 Biotechnology names. ZYME ranks #32 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DBVT |
DBV Technologies S.A.
|
5,213,361 | $108,907,111 | |
| 2 | CGEM |
Cullinan Therapeutics, Inc.
|
7,648,268 | $108,681,888 | |
| 3 | AKTS |
Aktis Oncology, Inc.
|
4,835,872 | $86,513,750 | |
| 4 | ALMS |
Alumis Inc.
|
2,386,529 | $52,575,233 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
1,660,696 | $52,311,924 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
506,776 | $49,283,966 | |
| 7 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,306,261 | $44,190,809 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
985,700 | $39,733,567 |
All Filings in ZYME
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,153,834 | 565,249 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||